Deltalab, S.L.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Deltalab, S.L. - overview
Established
1976
Location
Barcelona, -, Spain
Primary Industry
Medical Devices & Equipment
About
Deltalab, S. L. specializes in the design and manufacturing of single-use laboratory products, offering essential tools for clinical and research applications in over 125 countries. Founded in 1976, Deltalab, S.
L. operates from its headquarters in Barcelona, Spain, focusing on laboratory consumables. The company was acquired in June 2021 by SCG Packaging Public Company Limited for EUR 84. 90 million, with the current management, including CEO José Sáez, maintaining leadership.
This acquisition aims to bolster Deltalab's growth in the Asia Pacific healthcare market. Deltalab specializes in the design and manufacturing of single-use laboratory products. Its core offerings include high-quality pipette tips, swabs, and other essential laboratory consumables, catering to hospitals, clinics, industries, and universities worldwide. With a commitment to quality, Deltalab adheres to high sustainability standards and continuously invests in research and development for applications in microbiology, molecular biology, hematology, biochemistry, and histology.
In 2023, Deltalab reported a revenue of EUR 36,679,769. 10 and an EBITDA of EUR 2,695,323. 50. The company utilizes a B2B model, distributing products through a network of over 900 distributors, establishing long-lasting relationships with clients in the medical and academic sectors.
Deltalab plans to leverage the recent acquisition to enhance its product offerings and expand into the Asia Pacific market. The management team is focused on developing new products tailored to meet specific market needs. Funding from the recent EUR 84. 90 million acquisition will support these initiatives aimed at bolstering their presence in new global markets and launching innovative lab solutions.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.deltalab.es
Verticals
Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Deltalab, S.L. - timeline of key events
Deltalab, S.L. - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 25,889,752 | 27,580,321.1 | 28,648,100.8 | 28,926,159.9 | 28,597,793.7 | 43,537,789.4 | - | - | - |
| % Revenue Growth (YoY) | - | 6.5% | 3.9% | 1.0% | (1.1%) | 52.2% | - | - | - |
| EBITDA (USD) | 3,200,765.2 | 3,216,926.1 | 3,460,303.9 | 3,729,331.6 | 3,774,021 | 11,665,072.3 | - | - | - |
| Operating Income (USD) | 2,783,614.1 | 1,894,862.6 | 2,146,077.3 | 2,511,593.4 | 2,486,841.8 | 10,396,062 | - | - | - |
| Operating Margin | 10.8% | 6.9% | 7.5% | 8.7% | 8.7% | 23.9% | - | - | - |
| % EBITDA Margin | 12.4% | 11.7% | 12.1% | 12.9% | 13.2% | 26.8% | - | - | - |
| NET Income (USD) | 1,830,294.6 | 1,285,429.6 | 1,552,637.7 | 5,782,997.3 | 1,730,414.4 | 16,365,801.1 | - | - | - |
| % Net Margin | 7.1% | 4.7% | 5.4% | 20.0% | 6.1% | 37.6% | - | - | - |
Deltalab, S.L. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Deltalab, S.L. | - | ||||||||
| Secondary Buyout | Completed | Deltalab, S.L. | - | ||||||||
| Buyout | Completed | Deltalab, S.L. | - |
Displaying 1 - 3 of 3
Deltalab, S.L. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.